GILD eyes on $106.82: Key resistance before Trump pharma tariffsPharma next up in Trump's cross-hairs.
GILD is waiting at a moderate resistance.
News could dump it or break and rocket.
153,545.00
0.00 BRL
2.59 B BRL
154.87 B BRL
About Gilead Sciences, Inc.
Sector
Industry
CEO
Daniel P. O'Day
Website
Headquarters
Foster City
Founded
1987
ISIN
BRGILDBDR000
FIGI
BBG00CRHP5Y0
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases. It offers antiviral products under Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands. The company was founded by Michael L. Riordan on June 22, 1987 and is headquartered in Foster City, CA.
GILD is a dangerous buy, but a buy nonetheless for me.There is a lot NOT to like about this trade. Yes, I see how far it has run. Yes, I see how fast it is falling. Yes, I see the gap from 96 to 102 that “must” be filled. Yes, the market overall has been unhelpful of late. I realize all of it and I wouldn’t necessarily recommend anyone follow me
GILD - looks ready for a pull back. Some nice targets on GILD let's see how many we can get to. What do you think? Will break through stops and continue higher or flush? GL!
Gilead Sciences (GILD) Soars 4.93% on Strong Q4 Earnings ReportsGilead Sciences (NASDAQ: NASDAQ:GILD ) is making waves in the biotech sector after delivering a stellar fourth-quarter earnings report that not only crushed Wall Street expectations but also set the stage for a promising 2025. The stock surged 4.50% in premarket trading on Wednesday, signaling stro
Harmonic Within a Harmonic on Gilead. GILDThey are crooked looking, but are present. Another tangent of evidence on the obvious fractal nature of markets. That thick candle to us confirms break of trend and the underlying indicators are also suggestive. It is prudent to note that the indicator readings have been formed by price action, volu
$GILD Gilead Sciences Inc - Fib GP On Alert NASDAQ:GILD Gilead Sciences Inc -
-The ATH Fib Golden Pocket on alert for next week.
-Potential earnings Run-up
-Rotation
GILD Gilead Sciences Options Ahead of EarningsAnalyzing the options chain and the chart patterns of GILD Gilead Sciences prior to the earnings report this week,
I would consider purchasing the 89usd strike price Calls with
an expiration date of 2024-11-15,
for a premium of approximately $2.91.
If these options prove to be profitable prior to th
Gilead Pullback!Three bear bars is a concern but, with 2 different measured moves objects above and a solid trend upwards, I think its worth a shot for a long. If it is worth anything, the whole industry seems to be trending positively.
Gilead Sciences (GILD): Will Support Hold or Will We See a Drop?We've neglected Gilead Sciences for a while, but it's time for an update. Unfortunately, our entry looking back wasn't ideal, as the stock has fallen below the 61.8% retracement level. It found support just below the 78.6% level, which marks the bottom of our range. This level was precisely touched,
See all ideas
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
GILD5050849
Gilead Sciences, Inc. 2.8% 01-OCT-2050Yield to maturity
7.22%
Maturity date
Oct 1, 2050
US375558BS1
GILEAD SCIEN 20/40Yield to maturity
6.76%
Maturity date
Oct 1, 2040
US375558BK8
GILEAD SCIENCES 16/47Yield to maturity
6.55%
Maturity date
Mar 1, 2047
GILD4104362
Gilead Sciences, Inc. 4.8% 01-APR-2044Yield to maturity
6.45%
Maturity date
Apr 1, 2044
GILD4184058
Gilead Sciences, Inc. 4.5% 01-FEB-2045Yield to maturity
6.32%
Maturity date
Feb 1, 2045
GISE
GILEAD SCIENCES 2046Yield to maturity
6.29%
Maturity date
Mar 1, 2046
GILD5939386
Gilead Sciences, Inc. 5.6% 15-NOV-2064Yield to maturity
6.02%
Maturity date
Nov 15, 2064
GILD.GO
Gilead Sciences, Inc. 5.65% 01-DEC-2041Yield to maturity
5.93%
Maturity date
Dec 1, 2041
GILD5648609
Gilead Sciences, Inc. 5.55% 15-OCT-2053Yield to maturity
5.92%
Maturity date
Oct 15, 2053
GILD5939385
Gilead Sciences, Inc. 5.5% 15-NOV-2054Yield to maturity
5.90%
Maturity date
Nov 15, 2054
GISG
GILEAD SCIENCES 16/36Yield to maturity
5.77%
Maturity date
Sep 1, 2036
See all GILD34 bonds
Curated watchlists where GILD34 is featured.
